Evidence map›Paper›PMID 40266135›Full record

ArticleVaccines2025

Discrepancy in SARS-CoV-2 Infection Status Among PCR, Serological, and Cellular Immunity Assays of Nucleocapsids: A Historical Cohort Study.

Taiga Uchiyama, Yurie Kobashi, Takeshi Kawamura, Yoshitaka Nishikawa, Aya Nakayama, Fumiya Oguro, Yudai Kaneko, Chika Yamamoto, Naomi Ito, Tianchen Zhao and 4 more

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Taiga UchiyamaDepartment of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Fukushima, Japan.
Yurie KobashiDepartment of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Fukushima, Japan.ORCID 0000-0002-3442-3779
Takeshi KawamuraProteomics Laboratory, Isotope Science Center, The University of Tokyo, Tokyo 113-8654, Japan.
Yoshitaka NishikawaDepartment of General Internal Medicine, Hirata Central Hospital, Hirata 963-8202, Fukushima, Japan.
Aya NakayamaProteomics Laboratory, Isotope Science Center, The University of Tokyo, Tokyo 113-8654, Japan.
Fumiya OguroDepartment of General Internal Medicine, Hirata Central Hospital, Hirata 963-8202, Fukushima, Japan.
Yudai KanekoLaboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo 113-8654, Japan.
Chika YamamotoDepartment of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Fukushima, Japan.
Naomi ItoDepartment of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Fukushima, Japan.ORCID 0000-0002-0599-0328
Tianchen ZhaoDepartment of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Fukushima, Japan.ORCID 0000-0001-8602-6786
Hiroaki SaitoDepartment of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Fukushima, Japan.ORCID 0000-0002-0824-454X
Toshiki AbeDepartment of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Fukushima, Japan.ORCID 0009-0006-2496-8456
Tatsuhiko KodamaLaboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo 113-8654, Japan.
Masaharu TsubokuraDepartment of Radiation Health Management, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Fukushima, Japan.ORCID 0000-0001-8027-202X

Funding

Agency for Medical Research and Development JP21nf0101638JSPS KAKENHI 23H00503Kowa Co. N/AMedical & Biological Laboratories Co., Ltd. N/AModerna Inc. N/AResearch Center for Advanced Science and Technology in the University of Tokyo N/AShenzhen YHLO Biotech Co., Ltd. N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cellular immunityCOVID-19humoral immunitynucleocapsidSARS-CoV-2

Identifiers

PMID40266135
PMCPMC11945907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.